Search research articles
Contact Us
Filters
Showing results (11-20 of 36) with videos related to
Page
of 4
Sort By:
Cancer Immunology, Immunotherapy : CII
|
January 1, 1989
A phase-II study of low-dose cyclophosphamide and recombinant human interleukin-2 in metastatic renal cell carcinoma and malignant melanoma
A Lindemann, K Höffken, R E Schmidt, et al.
Clinical Immunology and Immunopathology
|
August 1, 1987
T-cell activation defect in common variable immunodeficiency: restoration by phorbol myristate acetate (PMA) or allogeneic macrophages
W Fiedler, K W Sykora, K Welte, et al.
Journal of Biological Response Modifiers
|
October 1, 1988
Phase I trial of recombinant interleukin-2 and cyclophosphamide: augmentation of cellular immunity and T-cell mitogenic response with long-term administration of rIL-2
J E Kolitz, G Y Wong, K Welte, et al.
Seminars in Oncology
|
June 1, 1992
A phase II pilot trial of high-dose hydroxyurea in chronic myelogenous leukemia
J E Kolitz, S J Kempin, A Schluger, et al.
Experimental Cell Biology
|
January 1, 1988
Anti-tumor efficacy of interleukin-2-activated killer cells in human neuroblastoma ex vivo
J Atzpodien, S C Gulati, J H Kwon, et al.
Journal of Biological Response Modifiers
|
August 1, 1987
Expansion of activated T-lymphocytes in patients treated with recombinant interleukin 2
J E Kolitz, K Welte, G Y Wong, et al.
Investigational New Drugs
|
September 1, 1988
A phase I trial of intraperitoneal recombinant interleukin 2 in patients with ovarian carcinoma
P B Chapman, J E Kolitz, T B Hakes, et al.
Leukemia Research
|
July 31, 2012
Pharmacokinetics of CPX-351; a nano-scale liposomal fixed molar ratio formulation of cytarabine:daunorubicin, in patients with advanced leukemia
E J Feldman, J E Kolitz, J M Trang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 16, 2001
Impact of therapy With chlorambucil, fludarabine, or fludarabine plus chlorambucil on infections in patients with chronic lymphocytic leukemia: Intergroup Study Cancer and Leukemia Group B 9011
V A Morrison, K R Rai, B L Peterson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 12, 1999
Extended Rituximab (anti-CD20 monoclonal antibody) therapy for relapsed or refractory low-grade or follicular non-Hodgkin's lymphoma
L D Piro, C A White, A J Grillo-López, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 36) with videos related to
Sort By:
Page
of 4
Cancer Immunology, Immunotherapy : CII
|
January 1, 1989
A phase-II study of low-dose cyclophosphamide and recombinant human interleukin-2 in metastatic renal cell carcinoma and malignant melanoma
A Lindemann, K Höffken, R E Schmidt, et al.
Clinical Immunology and Immunopathology
|
August 1, 1987
T-cell activation defect in common variable immunodeficiency: restoration by phorbol myristate acetate (PMA) or allogeneic macrophages
W Fiedler, K W Sykora, K Welte, et al.
Journal of Biological Response Modifiers
|
October 1, 1988
Phase I trial of recombinant interleukin-2 and cyclophosphamide: augmentation of cellular immunity and T-cell mitogenic response with long-term administration of rIL-2
J E Kolitz, G Y Wong, K Welte, et al.
Seminars in Oncology
|
June 1, 1992
A phase II pilot trial of high-dose hydroxyurea in chronic myelogenous leukemia
J E Kolitz, S J Kempin, A Schluger, et al.
Experimental Cell Biology
|
January 1, 1988
Anti-tumor efficacy of interleukin-2-activated killer cells in human neuroblastoma ex vivo
J Atzpodien, S C Gulati, J H Kwon, et al.
Journal of Biological Response Modifiers
|
August 1, 1987
Expansion of activated T-lymphocytes in patients treated with recombinant interleukin 2
J E Kolitz, K Welte, G Y Wong, et al.
Investigational New Drugs
|
September 1, 1988
A phase I trial of intraperitoneal recombinant interleukin 2 in patients with ovarian carcinoma
P B Chapman, J E Kolitz, T B Hakes, et al.
Leukemia Research
|
July 31, 2012
Pharmacokinetics of CPX-351; a nano-scale liposomal fixed molar ratio formulation of cytarabine:daunorubicin, in patients with advanced leukemia
E J Feldman, J E Kolitz, J M Trang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 16, 2001
Impact of therapy With chlorambucil, fludarabine, or fludarabine plus chlorambucil on infections in patients with chronic lymphocytic leukemia: Intergroup Study Cancer and Leukemia Group B 9011
V A Morrison, K R Rai, B L Peterson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 12, 1999
Extended Rituximab (anti-CD20 monoclonal antibody) therapy for relapsed or refractory low-grade or follicular non-Hodgkin's lymphoma
L D Piro, C A White, A J Grillo-López, et al.
Page
of 4